vcfirmsdirectory.com

SEC exempt reporting adviser · Early stage · Est. 2014

Fannin

Fannin is a Houston-based life sciences innovation studio that licenses drug and medical-device technologies from academic inventors and develops them using a mix of investor and grant funding.

HoustonRegistered · Houston
New investments · 12 months
Fund vehiclesPublic
11
11 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: fannininnovation.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Fannin joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Fannin right for your round?

Is Fannin a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
11
11 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

FANNIN PI HOLDINGS VII, LLCUS private fund · Active · United States · $28M gross assets · filed 25 Mar 2026
FANNIN PI HOLDINGS VI, LLCUS private fund · Active · United States · $12M gross assets · filed 25 Mar 2026
FANNIN PI HOLDINGS VIII, LLCUS private fund · Active · United States · $6M gross assets · filed 25 Mar 2026
FANNIN BREVITEST HOLDINGS I, LLCUS private fund · Active · United States · $5.1M gross assets · filed 25 Mar 2026
FANNIN ALLTERUM HOLDINGS II, LLCUS private fund · Active · United States · $4.2M gross assets · filed 25 Mar 2026
FANNIN ALLTERUM HOLDINGS I, LLCUS private fund · Active · United States · $4.1M gross assets · filed 25 Mar 2026
FANNIN PI HOLDINGS IV, LLCUS private fund · Active · United States · $4M gross assets · filed 25 Mar 2026
FANNIN PULMOTECT HOLDINGS V, LLCUS private fund · Active · United States · $3.9M gross assets · filed 25 Mar 2026
FANNIN PI HOLDINGS V, LLCUS private fund · Active · United States · $3.1M gross assets · filed 25 Mar 2026
FANNIN PULMOTECT HOLDINGS IV, LLCUS private fund · Active · United States · $1.9M gross assets · filed 25 Mar 2026
FANNIN PULMOTECT HOLDINGS III, LLCUS private fund · Active · United States · $1M gross assets · filed 25 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Fannin joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Fannin joined

Round sizes, Fannin’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

PROCYRION, INC.ALLTERUM THERAPEUTICS, INC.PULMOTECT, INC.

Portfolio and exits

Every company Fannin backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Fannin puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Fannin

Events where Fannin’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Fannin’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

25 Mar 2026Fund filingForm ADV filed by FANNIN ADVISORY, LLC: 11 private funds, $73.4M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Fannin is based in Houston, United States.

In 2014.

11 fund vehicles are on public registers (SEC adviser filings), including FANNIN PI HOLDINGS VII, LLC, FANNIN PI HOLDINGS VI, LLC and FANNIN PI HOLDINGS VIII, LLC.

Stages: Early stage. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.

Takes university-originated drug and device technologies and acts as both the operating team and the first investor, working alongside the inventors and tapping grants where suitable. The model targets cities with strong research but little commercialization infrastructure, and aims at serious unmet medical needs. From the firm’s own website.

Fannin lists 3 portfolio companies on its website: PROCYRION, INC., ALLTERUM THERAPEUTICS, INC. and PULMOTECT, INC..

Know before Fannin’s next round is announced.

PRO tracks Fannin’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

FanninGet Fannin’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.